At the 17th annual World Preclinical Congress in Boston mid-June technologies, trends and innovations within drug discovery and translational research. The congress gathers experts with a variety of scientific backgrounds such as chemistry, biology, pharmacology, toxicology and engineering as well as researchers within a variety of disease areas such as cancer and neuronal diseases. Representatives from industry, academia and technology providers will be present to share their challenges, solutions and knowhow.
Bioneer has state-of-the-art technology platforms within important areas like drug formulation & characterization, human disease models, recombinant protein production, and molecular histology & detection.
At the congress we look forward to talking to fellow scientists in the program themes like ‘iPS Cells for Disease Modeling and Drug Discovery’, ‘Blood-Brain-barrier models’, ‘Preclinical Strategies in Oncology’ etc.
If you wish to meet with Bioneer in Boston, please contact CSO Christian Clausen via email or Sales & Business Development Manager Lovisa M. Sunesson via email.
For more information about the event, read here.